- Home
- PSIX vs ARQT Comparison
PSIX vs ARQT Comparison
Compare PSIX & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSIX
- ARQT
- Stock Information
- Founded
- PSIX 1985
- ARQT 2016
- Country
- PSIX United States
- ARQT United States
- Employees
- PSIX N/A
- ARQT N/A
- Industry
- PSIX Industrial Machinery/Components
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- PSIX Industrials
- ARQT Health Care
- Exchange
- PSIX Nasdaq
- ARQT Nasdaq
- Market Cap
- PSIX 2.2B
- ARQT 2.1B
- IPO Year
- PSIX N/A
- ARQT 2020
- Fundamental
- Price
- PSIX $101.51
- ARQT $17.14
- Analyst Decision
- PSIX Strong Buy
- ARQT Strong Buy
- Analyst Count
- PSIX 1
- ARQT 7
- Target Price
- PSIX $37.00
- ARQT $19.00
- AVG Volume (30 Days)
- PSIX 663.5K
- ARQT 1.5M
- Earning Date
- PSIX 11-08-2025
- ARQT 11-05-2025
- Dividend Yield
- PSIX N/A
- ARQT N/A
- EPS Growth
- PSIX 146.48
- ARQT N/A
- EPS
- PSIX 4.81
- ARQT N/A
- Revenue
- PSIX $597,494,000.00
- ARQT $263,464,999.00
- Revenue This Year
- PSIX $29.80
- ARQT $72.46
- Revenue Next Year
- PSIX $11.99
- ARQT $31.69
- P/E Ratio
- PSIX $21.08
- ARQT N/A
- Revenue Growth
- PSIX 40.10
- ARQT 99.50
- 52 Week Low
- PSIX $15.30
- ARQT $8.03
- 52 Week High
- PSIX $121.78
- ARQT $18.15
- Technical
- Relative Strength Index (RSI)
- PSIX 64.66
- ARQT 59.14
- Support Level
- PSIX $83.40
- ARQT $16.62
- Resistance Level
- PSIX $95.82
- ARQT $18.15
- Average True Range (ATR)
- PSIX 5.81
- ARQT 0.69
- MACD
- PSIX 1.38
- ARQT 0.01
- Stochastic Oscillator
- PSIX 96.38
- ARQT 66.89
About PSIX Power Solutions International Inc. Common Stock
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.